Though UnitedHealth reported disappointing first-quarter results last week, two analysts from KeyBanc Capital Markets and Truist Securities remain bullish on the stock.
Latest Ratings for UNH
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2022 | SVB Leerink | Maintains | Outperform | |
| Jan 2022 | BMO Capital | Maintains | Market Perform | |
| Jan 2022 | Raymond James | Maintains | Strong Buy |
